A recent study by Weigand et al. (2020) among 301 older adults without dementia from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) contrasted cognitive performance across groups with and without amyloid and/or tau pathology. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.